Market Neuron Logo
⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

GRASIM - Investment Analysis: Buy Signal or Bull Trap?

Last Updated Time : 20 Dec 25, 07:05 am

Back to Investment List

Investment Rating: 2.9

Stock Code GRASIM Market Cap 1,91,512 Cr. Current Price 2,814 ₹ High / Low 2,979 ₹
Stock P/E 557 Book Value 808 ₹ Dividend Yield 0.36 % ROCE 1.52 %
ROE 0.35 % Face Value 2.00 ₹ DMA 50 2,783 ₹ DMA 200 2,726 ₹
Chg in FII Hold 0.58 % Chg in DII Hold -0.64 % PAT Qtr 805 Cr. PAT Prev Qtr -118 Cr.
RSI 56.7 MACD 7.87 Volume 2,61,897 Avg Vol 1Wk 4,94,081
Low price 2,276 ₹ High price 2,979 ₹ PEG Ratio -9.23 Debt to equity 0.24
52w Index 76.6 % Qtr Profit Var 6.31 % EPS 3.29 ₹ Industry PE 33.2

📊 Analysis: GRASIM shows weak fundamentals for long-term compounding. ROCE (1.52%) and ROE (0.35%) are far below desirable levels, indicating poor capital efficiency. Debt-to-equity (0.24) is manageable, but dividend yield (0.36%) is low, offering limited passive income. EPS (3.29 ₹) is very weak relative to price, and the P/E ratio (557) is severely overvalued compared to industry PE (33.2). Current price (2,814 ₹) is slightly above both 50 DMA (2,783 ₹) and 200 DMA (2,726 ₹), reflecting consolidation. RSI (56.7) indicates neutral momentum, while MACD (7.87) shows mild bullishness. Quarterly PAT improved to 805 Cr. from -118 Cr., but profit variation (+6.31%) is modest. PEG ratio (-9.23) highlights poor growth alignment. Overall, GRASIM is not a strong candidate for long-term investment, though short-term tactical exposure may be possible.

💰 Ideal Entry Zone: 2,650 ₹ – 2,750 ₹ (near 200 DMA support for margin of safety).

📈 Exit / Holding Strategy: Investors already holding should consider reducing exposure. Exit strategy: book profits near 2,950–3,000 ₹ (recent highs). Holding period should be short-term (1–2 years) only, as long-term compounding potential is limited by weak ROE/ROCE and stretched valuations.


Positive

Limitation

Company Negative News

Company Positive News

Industry

Conclusion

🔑 GRASIM is a weak candidate for long-term investment due to poor efficiency metrics, stretched valuations, and low EPS. Entry only near 2,650–2,750 ₹ for speculative exposure. Existing investors should consider exiting near 2,950–3,000 ₹. Long-term compounding potential is limited, making this stock better suited for short-term tactical trades rather than core portfolio holdings.

Would you like me to extend this into a peer benchmarking overlay comparing GRASIM against other diversified industrial players (like Ultratech, Aditya Birla Capital, and Shree Cement), or prepare a sector rotation basket scan to highlight safer alternatives for long-term compounding?

Back to Investment List

NIFTY 50 - Today Top Investment Picks Stock Picks

NEXT 50 - Today Top Investment Picks Stock Picks

MIDCAP - Today Top Investment Picks Stock Picks

SMALLCAP - Today Top Investment Picks Stock Picks